Aug 18, 2023, 17:22
New research led by Dr. Zhengping Zhuang’s team addresses the urgent need to develop new therapies for colorectal carcinoma (CRC) – NCI Neuro-Oncology Branch
NCI Neuro-Oncology Branch shared on their Twitter page:
“New research led by Dr. Zhengping Zhuang‘s team addresses the urgent need to develop new therapies for colorectal carcinoma (CRC). They found potential in TP5, a novel therapy that inhibits CDK5—an enzyme linked to CRC progression.”
For the article click here.
Source: NCI Neuro-Oncology Branch/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14